- Key insight: Discover how interventional psychiatry and cardiometabolic screening are shifting employer benefits.
- What’s at stake: Rising chronic-condition spend could destabilize plan costs and broker value propositions.
- Forward look: Brokers must adapt as employers demand validated clinical screenings and interventional mental-health solutions.
Source: Bullets generated by AI with editorial review
Bruce Shutan
Contributing writer
Bruce Shutan is an Employee Benefit News contributing writer based in Portland, Oregon.
